Development of a novel plaque reduction neutralisation test for hantavirus infection

<p>In the Americas, hantaviruses cause severe cardiopulmonary syndrome (HCPS) with a high fatality rate. Hantavirus infection is commonly diagnosed using serologic techniques and reverse transcription-polymerase chain reaction. This paper presents a novel plaque reduction neutralisation test (...

Full description

Bibliographic Details
Main Authors: Michelly de Pádua, William Marciel de Souza, Flávio Lauretti, Luiz Tadeu Moraes Figueiredo
Format: Article
Language:English
Published: Instituto Oswaldo Cruz, Ministério da Saúde 2015-08-01
Series:Memórias do Instituto Oswaldo Cruz.
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762015000500624&lng=en&tlng=en
id doaj-0276e17e6efb4ad49afd21c7adbe2641
record_format Article
spelling doaj-0276e17e6efb4ad49afd21c7adbe26412020-11-24T22:32:46ZengInstituto Oswaldo Cruz, Ministério da SaúdeMemórias do Instituto Oswaldo Cruz.1678-80602015-08-01110562462810.1590/0074-02760150102S0074-02762015000500624Development of a novel plaque reduction neutralisation test for hantavirus infectionMichelly de PáduaWilliam Marciel de SouzaFlávio LaurettiLuiz Tadeu Moraes Figueiredo<p>In the Americas, hantaviruses cause severe cardiopulmonary syndrome (HCPS) with a high fatality rate. Hantavirus infection is commonly diagnosed using serologic techniques and reverse transcription-polymerase chain reaction. This paper presents a novel plaque reduction neutralisation test (PRNT) for detecting antibodies to Brazilian hantavirus. Using PRNT, plaque detection was enhanced by adding 0.6% of dimethyl sulfoxide into the overlay culture medium of the infected cells. This procedure facilitated clear visualisation of small plaques under the microscope and provided for easy and accurate plaque counting. The sera from 37 HCPS patients from the city of Ribeirão Preto, Brazil was evaluated for the Rio Mamoré virus (RIOMV) using PRNT. Six samples exhibited neutralising antibodies; these antibodies exhibited a low titre. The low level of seropositive samples may be due to fewer cross-reactions between two different hantavirus species; the patients were likely infected by Araraquara virus (a virus that has not been isolated) and RIOMV was used for the test. This assay offers a new approach to evaluating and measuring neutralising antibodies produced during hantavirus infections and it can be adapted to other hantaviruses, including viruses that will be isolated in the future.</p>http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762015000500624&lng=en&tlng=enhantavirusplaque reduction neutralisation testcross-reaction in neutralisation testRio Mamoré virus
collection DOAJ
language English
format Article
sources DOAJ
author Michelly de Pádua
William Marciel de Souza
Flávio Lauretti
Luiz Tadeu Moraes Figueiredo
spellingShingle Michelly de Pádua
William Marciel de Souza
Flávio Lauretti
Luiz Tadeu Moraes Figueiredo
Development of a novel plaque reduction neutralisation test for hantavirus infection
Memórias do Instituto Oswaldo Cruz.
hantavirus
plaque reduction neutralisation test
cross-reaction in neutralisation test
Rio Mamoré virus
author_facet Michelly de Pádua
William Marciel de Souza
Flávio Lauretti
Luiz Tadeu Moraes Figueiredo
author_sort Michelly de Pádua
title Development of a novel plaque reduction neutralisation test for hantavirus infection
title_short Development of a novel plaque reduction neutralisation test for hantavirus infection
title_full Development of a novel plaque reduction neutralisation test for hantavirus infection
title_fullStr Development of a novel plaque reduction neutralisation test for hantavirus infection
title_full_unstemmed Development of a novel plaque reduction neutralisation test for hantavirus infection
title_sort development of a novel plaque reduction neutralisation test for hantavirus infection
publisher Instituto Oswaldo Cruz, Ministério da Saúde
series Memórias do Instituto Oswaldo Cruz.
issn 1678-8060
publishDate 2015-08-01
description <p>In the Americas, hantaviruses cause severe cardiopulmonary syndrome (HCPS) with a high fatality rate. Hantavirus infection is commonly diagnosed using serologic techniques and reverse transcription-polymerase chain reaction. This paper presents a novel plaque reduction neutralisation test (PRNT) for detecting antibodies to Brazilian hantavirus. Using PRNT, plaque detection was enhanced by adding 0.6% of dimethyl sulfoxide into the overlay culture medium of the infected cells. This procedure facilitated clear visualisation of small plaques under the microscope and provided for easy and accurate plaque counting. The sera from 37 HCPS patients from the city of Ribeirão Preto, Brazil was evaluated for the Rio Mamoré virus (RIOMV) using PRNT. Six samples exhibited neutralising antibodies; these antibodies exhibited a low titre. The low level of seropositive samples may be due to fewer cross-reactions between two different hantavirus species; the patients were likely infected by Araraquara virus (a virus that has not been isolated) and RIOMV was used for the test. This assay offers a new approach to evaluating and measuring neutralising antibodies produced during hantavirus infections and it can be adapted to other hantaviruses, including viruses that will be isolated in the future.</p>
topic hantavirus
plaque reduction neutralisation test
cross-reaction in neutralisation test
Rio Mamoré virus
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762015000500624&lng=en&tlng=en
work_keys_str_mv AT michellydepadua developmentofanovelplaquereductionneutralisationtestforhantavirusinfection
AT williammarcieldesouza developmentofanovelplaquereductionneutralisationtestforhantavirusinfection
AT flaviolauretti developmentofanovelplaquereductionneutralisationtestforhantavirusinfection
AT luiztadeumoraesfigueiredo developmentofanovelplaquereductionneutralisationtestforhantavirusinfection
_version_ 1725732542467801088